184 related articles for article (PubMed ID: 38184831)
1. Clinicopathological characteristics and prognostic factors of atypical meningiomas with bone invasion: a retrospective analysis of nine cases and literature review.
Cucu AI; Costea CF; Macovei G; Dumitrescu GF; Sava A; Blaj LA; Prutianu I; Porumb-Andrese E; Dascălu CG; Coşman M; Poeată I; Turliuc Ş
Rom J Morphol Embryol; 2023; 64(4):509-515. PubMed ID: 38184831
[TBL] [Abstract][Full Text] [Related]
2. Histopathological and Clinical Features as Prognostic Factors of Atypical Meningiomas.
Karabagli P; Karabagli H; Mavi Z; Demir F; Ozkeles EY
Turk Neurosurg; 2020; 30(5):746-575. PubMed ID: 32705671
[TBL] [Abstract][Full Text] [Related]
3. Benign versus atypical meningiomas: risk factors predicting recurrence.
Nowak A; Dziedzic T; Krych P; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(1):1-10. PubMed ID: 25666766
[TBL] [Abstract][Full Text] [Related]
4. Tumor recurrence in parasagittal and falcine atypical meningiomas invading the superior sagittal sinus.
Cucu AI; Turliuc MD; Costea CF; Dascălu CG; Dumitrescu GF; Sava A; Turliuc Ş; Scripcariu DV; Poeată I
Rom J Morphol Embryol; 2020; 61(2):385-395. PubMed ID: 33544790
[TBL] [Abstract][Full Text] [Related]
5. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
[TBL] [Abstract][Full Text] [Related]
6. Predictor factors for recurrence in atypical meningiomas.
Cucu AI; Costea CF; Turliuc Ş; Blaj LA; Prutianu I; Dumitrescu GF; Dascălu CG; Poeată I; Coşman M; Istrate AC; Macovei G; Tătăranu LG
Rom J Morphol Embryol; 2023; 64(3):333-342. PubMed ID: 37867351
[TBL] [Abstract][Full Text] [Related]
7. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
8. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
9. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
[TBL] [Abstract][Full Text] [Related]
11. Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection.
Mooney MA; Abolfotoh M; Bi WL; Tavanaiepour D; Almefty RO; Bassiouni H; Pravdenkova S; Dunn IF; Al-Mefty O
Neurosurgery; 2020 Oct; 87(5):900-909. PubMed ID: 32294205
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
14. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
15. A radiopathological classification of dural tail sign of meningiomas.
Qi ST; Liu Y; Pan J; Chotai S; Fang LX
J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
18. Atypical meningioma: a study of prognostic factors.
Zaher A; Abdelbari Mattar M; Zayed DH; Ellatif RA; Ashamallah SA
World Neurosurg; 2013 Nov; 80(5):549-53. PubMed ID: 23871812
[TBL] [Abstract][Full Text] [Related]
19. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
[TBL] [Abstract][Full Text] [Related]
20. Intracranial angiomatous meningiomas: A 15-year, multicenter study.
Ben Nsir A; Chabaane M; Krifa H; Jeme H; Hattab N
Clin Neurol Neurosurg; 2016 Oct; 149():111-7. PubMed ID: 27513979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
